Neurobiology and Therapeutic Potential of α5-GABA Type A Receptors
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
α5 subunit containing GABA type A receptors (GABAARs) have long been an enigmatic receptor subtype of interest due to their specific brain distribution, unusual surface localization and key role in synaptic plasticity, cognition and memory. These receptors are uniquely positioned to sculpt both the developing and mature hippocampal circuitry due to high overall expression and a distinct peak during the critical synapse formation period during the second postnatal week. Unlike the majority of other GABAARs, they exhibit both receptor clustering at extrasynaptic sites via interactions with the radixin scaffold as well as synaptic sites via gephyrin, thus contributing respectively to tonic currents and synaptic GABAergic neurotransmission. α5 GABAAR signaling can be altered in neurodevelopmental disorders including autism and mental retardation and by inflammation in CNS injury and disease. Due to the unique physiology and pharmacology of α5 GABAARs, drugs targeting these receptors are being developed and tested as treatments for neurodevelopmental disorders, depression, schizophrenia, and mild cognitive impairment. This review focuses on advances in understanding how the α5 subunit contributes to GABAAR neurobiology. In particular I discuss both recent insights and remaining knowledge gaps for the functional role of these receptors, pathologies associated with α5 GABAAR dysfunction, and the effects and potential therapeutic uses of α5 receptor subtype targeted drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Excitatory actions of gaba during development: the nature of the nurture
Ben-Ari, Y. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn920 · Cited by 2,448 · cited 1×
“During the first postnatal week, tonic α5 currents enhance cell excitability and synaptic activity, facilitating the induction of giant depolarizing potentials, which are important for early network maturation (Ben-Ari, 2002; Marchionni et al., 2007).”
BackgroundThe GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934
Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke
Clarkson, A. N., Huang, B. S., MacIsaac, S. E., Mody, I., & Carmichael, S. T. (2010) · Nature · doi:10.1038/nature09511 · Cited by 869
Collinson, N., Kuenzi, F. M., Jarolimek, W., Maubach, K. A., Cothliff, R., Sur, C., Smith, A., Otu, F. M., Howell, O., Atack, J. R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05572.2002 · Cited by 628 · cited 2×
“Behaviorally, the increased excitability of Gabra5−/− hippocampal pyramidal neurons was correlated with improved performance in a spatial learning behavior (Collinson et al., 2002), though later studies were not able to replicate this result (Cheng et al., 2006; Martin et al., 2009b).”
BackgroundResultA rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages
Yu, Y., Fuscoe, J. C., Zhao, C., Guo, C., Jia, M., Qing, T., Bannon, D. I., Lancashire, L., Bao, W., Du, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms4230 · Cited by 395
Which GABA A Receptor Subunits Are Necessary for Tonic Inhibition in the Hippocampus?
Glykys, J., Mann, E. O., & Mody, I. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4751-07.2008 · Cited by 370 · cited 3×
“In addition, Gabra5−/− mice showed greater power of kainate-induced gamma frequency oscillations (Towers et al., 2004), and knockout of delta and α5 subunits led to spontaneous gamma oscillations in CA3 (Glykys et al., 2008).”
BackgroundHan, S., Tai, C., Jones, C. J., Scheuer, T., & Catterall, W. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.016 · Cited by 231
An emerging circuit pharmacology of GABAA receptors
Engin, E., Benham, R. S., & Rudolph, U. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.04.003 · Cited by 225 · cited 1×
“It is clear that improving understanding of GABAAR subtype subcellular (extrasynaptic vs. synaptic) and circuit-specific localization and function are critical areas of current research and future pharmacological development (reviewed in Engin et al., 2018).”
BackgroundFuchs, T., Jefferson, S. J., Hooper, A., Yee, P.-H., Maguire, J., & Luscher, B. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.188 · Cited by 204
Hausrat, T. J., Muhia, M., Gerrow, K., Thomas, P., Hirdes, W., Tsukita, S., Heisler, F. F., Herich, L., Dubroqua, S., Breiden, P., et al. (2015) · Nature Communications · doi:10.1038/ncomms7872 · Cited by 138 · cited 2×
“Phosphorylated radixin scaffolds α5βγ2 receptors to the actin cytoskeleton, ultimately reducing diffusion rates and concentrating channel activity away from axon terminals (Hausrat et al., 2015).”
Background
Research works printed but not linked: 87
- Ambrad Giovannetti, 2019, Unsupervised excitation: GABAergic dysfunctions in Alzheimer’s disease, Brain Res., 1707, 216, 10.1016/j.brainres.2018.11.042 · DOI · Paper page
- Araujo, 1999, Native γ-aminobutyric acid type A receptors from rat hippocampus, containing both α 1 and α 5 subunits, exhibit a single benzodiazepine binding site with α 5 pharmacological properties, J. Pharmacol. Exp. Ther., 290, 989
- Atack, 2010, Preclinical and clinical pharmacology of the GABAA receptor α5 subtype-selective inverse agonist α5IA, Pharmacol. Ther., 125, 11, 10.1016/j.pharmthera.2009.09.001 · DOI
- Atack, 2011, GABAA receptor subtype-selective modulators: II. α5-selective inverse agonists for cognition enhancement, Curr. Top. Med. Chem., 11, 1203, 10.2174/156802611795371314 · DOI
- Atack, 2006, L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for α5-containing GABAA receptors, Neuropharmacology, 51, 1023, 10.1016/j.neuropharm.2006.04.018 · DOI · Paper page
- Atack, 2009, In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)- pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor α5 subtype-selective inverse agonist, J. Pharmacol. Exp. Ther., 331, 470, 10.1124/jpet.109.157636 · DOI
- Bader, 2017, Functional characterization of GABAA receptor-mediated modulation of cortical neuron network activity in microelectrode array recordings, PLoS One, 12, e0186147, 10.1371/journal.pone.0186147 · DOI
- Bakker, 2003, Understanding fragile X syndrome: insights from animal models, Cytogenet. Genome Res., 100, 111, 10.1159/000072845 · DOI
- Balic, 2009, The α5(H105R) mutation impairs α5 selective binding properties by altered positioning of the α5 subunit in GABAA receptors containing two distinct types of α subunits, J. Neurochem., 110, 244, 10.1111/j.1471-4159.2009.06119.x · DOI
- Ballard, 2009, RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors, Psychopharmacology, 202, 207, 10.1007/s00213-008-1357-7 · DOI
- Ben-Ari, 2007, GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations, Physiol. Rev., 87, 1215, 10.1152/physrev.00017.2006 · DOI · Paper page
- Bonin, 2007, α5GABAA receptors regulate the intrinsic excitability of mouse hippocampal pyramidal neurons, J. Neurophysiol., 98, 2244, 10.1152/jn.00482.2007 · DOI
- Brady, 2015, Synaptic localization of α5 GABAA receptors via gephyrin interaction regulates dendritic outgrowth and spine maturation, Dev. Neurobiol., 75, 1241, 10.1002/dneu.22280 · DOI
- Braudeau, 2011, Chronic treatment with a promnesiant GABA-A α5-selective inverse agonist increases immediate early genes expression during memory processing in mice and rectifies their expression levels in a down syndrome mouse model, Adv. Pharmacol. Sci., 2011, 153218, 10.1155/2011/153218 · DOI · Paper page
- Brünig, 2002, Intact sorting, targeting, and clustering of γ-aminobutyric acid A receptor subtypes in hippocampal neurons in vitro, J. Comp. Neurol., 443, 43, 10.1002/cne.10102 · DOI · Paper page
- Butler, 2018, De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy, Brain, 141, 2392, 10.1093/brain/awy171 · DOI · Paper page
- Caraiscos, 2004, Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by α5 subunit-containing γ-aminobutyric acid type A receptors, Proc. Natl. Acad. Sci. U S A, 101, 3662, 10.1073/pnas.0307231101 · DOI · Paper page
- Chambers, 2002, 6,7-Dihydro-2-benzothiophen-4(5H)-ones: a novel class of GABA-A α5 receptor inverse agonists, J. Med. Chem., 45, 1176, 10.1021/jm010471b · doi:10.1021/jm010471b
- Chambers, 2003, Identification of a novel, selective GABAA α5 receptor inverse agonist which enhances cognition, J. Med. Chem., 46, 2227, 10.1021/jm020582q · DOI
- Chen, 2017, Physiological and pharmacological properties of inhibitory postsynaptic currents mediated by α5β1γ2, α5β2γ2 and α5β3γ2 GABAA receptors, Neuropharmacology, 125, 243, 10.1016/j.neuropharm.2017.07.027 · DOI
- Cheng, 2006, α5GABAA receptors mediate the amnestic but not sedative-hypnotic effects of the general anesthetic etomidate, J. Neurosci., 26, 3713, 10.1523/JNEUROSCI.5024-05.2006 · DOI · Paper page
- Christie, 2002, α5 subunit-containing GABAA receptors form clusters at GABAergic synapses in hippocampal cultures, Neuroreport, 13, 2355, 10.1097/00001756-200212030-00037 · DOI
- Clayton, 2015, A review of the updated pharmacophore for the α 5 GABAA benzodiazepine receptor model, Int. J. Med. Chem., 2015, 430248, 10.1155/2015/430248 · DOI
- Crestani, 2002, Trace fear conditioning involves hippocampal α5 GABAA receptors, Proc. Natl. Acad. Sci. U S A, 99, 8980, 10.1073/pnas.142288699 · DOI · Paper page
- Curia, 2009, Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome, Cereb. Cortex, 19, 1515, 10.1093/cercor/bhn159 · DOI · Paper page
- Deidda, 2015, Reversing excitatory GABAA signaling restores synaptic plasticity and memory in a mouse model of Down syndrome, Nat. Med., 21, 318, 10.1038/nm.3827 · DOI · Paper page
- del Río, 2001, Prevalence between different α subunits performing the benzodiazepine binding sites in native heterologous GABAA receptors containing the α2 subunit, J. Neurochem., 79, 183, 10.1046/j.1471-4159.2001.00551.x · DOI
- Deprez, 2016, Partial inactivation of GABAA receptors containing the α5 subunit affects the development of adult-born dentate gyrus granule cells, Eur. J. Neurosci., 44, 2258, 10.1111/ejn.13329 · DOI
- Etherington, 2017, Selective inhibition of extra-synaptic α5-GABAA receptors by S44819, a new therapeutic agent, Neuropharmacology, 125, 353, 10.1016/j.neuropharm.2017.08.012 · DOI
- Ge, 2006, GABA regulates synaptic integration of newly generated neurons in the adult brain, Nature, 439, 589, 10.1038/nature04404 · DOI · Paper page
- Gill, 2011, A novel α5GABAAR-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia, Neuropsychopharmacology, 36, 1903, 10.1038/npp.2011.76 · DOI · Paper page
- Giusi, 2009, Distinct α subunits of the GABAA receptor are responsible for early hippocampal silent neuron-related activities, Hippocampus, 19, 1103, 10.1002/hipo.20584 · DOI
- Glykys, 2006, Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABAA receptor α5 subunit-deficient mice, J. Neurophysiol., 95, 2796, 10.1152/jn.01122.2005 · DOI · Paper page
- Hauser, 2005, Hippocampal α5 subunit-containing GABAA receptors modulate the expression of prepulse inhibition, Mol. Psychiatry, 10, 201, 10.1038/sj.mp.4001554 · DOI
- Herd, 2008, The expression of GABAAβ subunit isoforms in synaptic and extrasynaptic receptor populations of mouse dentate gyrus granule cells, J. Physiol., 586, 989, 10.1113/jphysiol.2007.146746 · DOI
- Hernandez, 2016, Deleterious rare variants reveal risk for loss of GABAA receptor function in patients with genetic epilepsy and in the general population, PLoS One, 11, e0162883, 10.1371/journal.pone.0162883 · DOI
- Hogart, 2010, The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13, Neurobiol. Dis., 38, 181, 10.1016/j.nbd.2008.08.011 · DOI · Paper page
- Hu, 2018, Cell type-specific gene expression of α 5 subunit-containing γ-aminobutyric acid subtype A receptors in human and mouse frontal cortex, Mol. Neuropsychiatry, 4, 204, 10.1159/000495840 · DOI
- Ju, 2009, Distinct properties of murine α5 γ-aminobutyric acid type a receptors revealed by biochemical fractionation and mass spectroscopy, J. Neurosci. Res., 87, 1737, 10.1002/jnr.21991 · DOI
- Kazdoba, 2016, Translational mouse models of autism: advancing toward pharmacological therapeutics, Curr. Top. Behav. Neurosci., 28, 1, 10.1007/7854_2015_5003 · DOI · Paper page
- Koh, 2013, Selective GABAA α5 positive allosteric modulators improve cognitive function in aged rats with memory impairment, Neuropharmacology, 64, 145, 10.1016/j.neuropharm.2012.06.023 · DOI
- Laverty, 2019, Cryo-EM structure of the human α1β3γ2 GABAA receptor in a lipid bilayer, Nature, 565, 516, 10.1038/s41586-018-0833-4 · DOI · Paper page
- Lecker, 2013, Potentiation of GABAA receptor activity by volatile anaesthetics is reduced by α5GABAA receptor-preferring inverse agonists, Br. J. Anaesth., 110, i73, 10.1093/bja/aet038 · DOI
- Lévi, 2015, Benzodiazepine ligands rapidly influence GABAA receptor diffusion and clustering at hippocampal inhibitory synapses, Neuropharmacology, 88, 199, 10.1016/j.neuropharm.2014.06.002 · DOI
- Ling, 2015, A novel GABAA α 5 receptor inhibitor with therapeutic potential, Eur. J. Pharmacol., 764, 497, 10.1016/j.ejphar.2015.07.005 · DOI
- Lisman, 2008, A neural coding scheme formed by the combined function of gamma and theta oscillations, Schizophr. Bull., 34, 974, 10.1093/schbul/sbn060 · DOI · Paper page
- Lissemore, 2018, Reduced GABAergic cortical inhibition in aging and depression, Neuropsychopharmacology, 43, 2277, 10.1038/s41386-018-0093-x · DOI
- Liu, 1998, The α5 subunit of the murine type A GABA receptor, Mol. Brain Res., 59, 84, 10.1016/s0169-328x(98)00144-2 · doi:10.1016/s0169-328x(98)00144-2
- Loebrich, 2006, Activated radixin is essential for GABAA receptor α5 subunit anchoring at the actin cytoskeleton, EMBO J., 25, 987, 10.1038/sj.emboj.7600995 · DOI · Paper page
- Lorenz-Guertin, 2019, Diazepam accelerates GABAAR synaptic exchange and alters intracellular trafficking, Cell. Neurosci., 13, 163, 10.3389/fncel.2019.00163 · DOI
- Lucas-Osma, 2018, Extrasynaptic α5GABAA receptors on proprioceptive afferents produce a tonic depolarization that modulates sodium channel function in the rat spinal cord, J. Neurophysiol., 120, 2953, 10.1152/jn.00499.2018 · DOI
- Magnin, 2019, Input-specific synaptic location and function of the α5 GABAA receptor subunit in the mouse CA1 hippocampal neurons, J. Neurosci., 39, 788, 10.1523/JNEUROSCI.0567-18.2018 · DOI · Paper page
- Marchionni, 2007, In the developing rat hippocampus a tonic GABAA-mediated conductance selectively enhances the glutamatergic drive of principal cells, J. Physiol., 581, 515, 10.1113/jphysiol.2006.125609 · DOI
- Martin, The physiological properties and therapeutic potential of α5-GABAA receptors, Biochem. Soc. Trans., 37, 1334, 10.1042/BST0371334 · DOI
- Martin, Etomidate targets α5 γ-aminobutyric acid subtype A receptors to regulate synaptic plasticity and memory blockade, Anesthesiology, 111, 1025, 10.1097/ALN.0b013e3181bbc961 · DOI · Paper page
- Martin, 2010, α5GABAA receptor activity sets the threshold for long-term potentiation and constrains hippocampus-dependent memory, J. Neurosci., 30, 5269, 10.1523/JNEUROSCI.4209-09.2010 · DOI · Paper page
- Martínez-Cué, 2013, Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome, J. Neurosci., 33, 3953, 10.1523/JNEUROSCI.1203-12.2013 · DOI · Paper page
- Masiulis, 2019, GABAA receptor signalling mechanisms revealed by structural pharmacology, Nature, 565, 454, 10.1038/s41586-018-0832-5 · DOI · Paper page
- Mendez, 2013, The brain GABA-benzodiazepine receptor α-5 subtype in autism spectrum disorder: a pilot [11C]Ro15–4513 positron emission tomography study, Neuropharmacology, 68, 195, 10.1016/j.neuropharm.2012.04.008 · DOI
- Mesbah-Oskui, 2017, Reduced expression of α5GABAA receptors elicits autism-like alterations in EEG patterns and sleep-wake behavior, Neurotoxicol. Teratol., 61, 115, 10.1016/j.ntt.2016.10.009 · DOI
- Olsen, 2009, GABAA receptors: subtypes provide diversity of function and pharmacology, Neuropharmacology, 56, 141, 10.1016/j.neuropharm.2008.07.045 · DOI · Paper page
- Pangratz-Fuehrer, 2016, Early postnatal switch in GABAA receptor α-subunits in the reticular thalamic nucleus, J. Neurophysiol., 115, 1183, 10.1152/jn.00905.2015 · DOI
- Perez-Sanchez, 2017, α5GABAA receptors mediate tonic inhibition in the spinal cord dorsal horn and contribute to the resolution of hyperalgesia, J. Neurosci. Res., 95, 1307, 10.1002/jnr.23981 · DOI
- Phulera, 2018, Cryo-EM structure of the benzodiazepine-sensitive α1β1γ2S tri-heteromeric GABAA receptor in complex with GABA, eLife, 7, e39383, 10.7554/elife.39383 · DOI · Paper page
- Piantadosi, 2016, Sex-dependent anti-stress effect of an α5 subunit containing GABAA receptor positive allosteric modulator, Front. Pharmacol., 7, 446, 10.3389/fphar.2016.00446 · DOI · Paper page
- Prenosil, 2006, Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons, J. Neurophysiol., 96, 846, 10.1152/jn.01199.2006 · doi:10.1152/jn.01199.2006 · Paper page
- Prevot, 2019, Novel benzodiazepine-like ligands with various anxiolytic, antidepressant, or pro-cognitive profiles, Mol. Neuropsychiatry, 5, 84, 10.1159/000496086 · DOI · Paper page
- Ramos, 2004, Expression of α 5 GABAA receptor subunit in developing rat hippocampus, Dev. Brain Res., 151, 87, 10.1111/j.0953-816x.2004.03349.x · DOI · Paper page
- Renner, 2012, Diffusion barriers constrain receptors at synapses, PLoS One, 7, e43032, 10.1371/journal.pone.0043032 · DOI
- Rozycka, 2017, The space where aging acts: focus on the GABAergic synapse, Aging Cell, 16, 634, 10.1111/acel.12605 · DOI · Paper page
- Saab, 2010, Short-term memory impairment after isoflurane in mice is prevented by the α5 γ-aminobutyric acid type A receptor inverse agonist L-655,708, Anesthesiology, 113, 1061, 10.1097/ALN.0b013e3181f56228 · DOI
- Schulz, 2018, Dendrite-targeting interneurons control synaptic NMDA-receptor activation via nonlinear α5-GABAA receptors, Nat. Commun., 9, 3576, 10.1038/s41467-018-06004-8 · DOI
- Schulz, 2019, Enhanced dendritic inhibition and impaired NMDAR activation in a mouse model of down syndrome, J. Neurosci., 39, 5210, 10.1523/JNEUROSCI.2723-18.2019 · DOI
- Serwanski, 2006, Synaptic and nonsynaptic localization of GABAA receptors containing the α5 subunit in the rat brain, J. Comp. Neurol., 499, 458, 10.1002/cne.21115 · DOI · Paper page
- Sieghart, 2018, International union of basic and clinical pharmacology. CVI: GABAA receptor subtype- and function-selective ligands: key issues in translation to humans, Pharmacol. Rev., 70, 836, 10.1124/pr.117.014449 · DOI · Paper page
- Street, 2004, Synthesis and biological evaluation of 3-Heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABAAα5 benzodiazepine binding site, J. Med. Chem., 47, 3642, 10.1021/jm0407613 · DOI
- Sur, 1999, Autoradiographic localization of α5 subunit-containing GABAA receptors in rat brain, Brain Res., 822, 265, 10.1016/s0006-8993(99)01152-x · DOI
- Sur, 1998, Rat and human hippocampal α5 subunit-containing γ-aminobutyric AcidA receptors have α5 β3 γ2 pharmacological characteristics, Mol. Pharmacol., 54, 928, 10.1124/mol.54.5.928 · DOI
- Towers, 2004, α 5 subunit-containing GABAA receptors affect the dynamic range of mouse hippocampal kainate-induced γ frequency oscillations in vitro, J. Physiol., 559, 721, 10.1113/jphysiol.2004.071191 · DOI
- Vargas-Caballero, 2010, α5 Subunit-containing GABAA receptors mediate a slowly decaying inhibitory synaptic current in CA1 pyramidal neurons following Schaffer collateral activation, Neuropharmacology, 58, 668, 10.1016/j.neuropharm.2009.11.005 · DOI
- Vidal, 2018, Decreasing the expression of GABAA α5 subunit-containing receptors partially improves cognitive, electrophysiological, and morphological hippocampal defects in the Ts65Dn model of down syndrome, Mol. Neurobiol., 55, 4745, 10.1007/s12035-017-0675-3 · DOI
- Wang, 2012, Memory deficits induced by inflammation are regulated by α5-subunit-containing GABAA receptors, Cell Rep., 2, 488, 10.1016/j.celrep.2012.08.022 · DOI · Paper page
- Zarnowska, 2009, GABAA receptor α5 subunits contribute to GABAA,slow synaptic inhibition in mouse hippocampus, J. Neurophysiol., 101, 1179, 10.1152/jn.91203.2008 · DOI · Paper page
- Zhao, 2019, Inhibition of α5 GABAA receptors has preventive but not therapeutic effects on isoflurane-induced memory impairment in aged rats, Neural Regen. Res., 14, 1029, 10.4103/1673-5374.250621 · DOI
- Zhu, 2018, Structure of a human synaptic GABAA receptor, Nature, 559, 67, 10.1038/s41586-018-0255-3 · DOI · Paper page
- Zurek, 2016, α5GABAA receptor deficiency causes autism-like behaviors, Ann. Clin. Transl. Neurol., 3, 392, 10.1002/acn3.303 · DOI
- Zurek, 2014, Sustained increase in α5GABAA receptor function impairs memory after anesthesia, J. Clin. Invest., 124, 5437, 10.1172/JCI76669 · DOI · Paper page
Cited by
Anderson, A. G., Rogers, B. B., Loupe, J. M., Rodriguez-Nunez, I., Roberts, S. C., White, L. M., Brazell, J. N., Bunney, W. E., Bunney, B. G., Watson, S. J., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100263 · Cited by 82
Yuan, X., Chai, J., Xu, W., & Zhao, Y. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10326-z · Cited by 15
Recruitment of Plasma Membrane GABA-A Receptors by Submembranous Gephyrin/Collybistin Clusters
George, S., Chiou, T.-T., Kanamalla, K., & De Blas, A. L. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01050-1 · Cited by 8
Metadata
- Authors
- Jacob, T. C.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-07-24
- Volume
- 12
- Pages
- 179-179
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2960913096
- Cited by
- 122
- References
- 15
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- National Institute of Mental Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurobiology and Therapeutic Potential of α5-GABA Type A Receptors. https://app.cochat.ai/papers/10.3389/fnmol.2019.00179
- The paper
- Jacob, T. C. (2019). Neurobiology and Therapeutic Potential of α5-GABA Type A Receptors. Frontiers in Molecular Neuroscience. https://doi.org/10.3389/fnmol.2019.00179
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.